Expert View: Wearable Technology And The FDA Adoption Curve
This article was originally published in Scrip
The US FDA recently announced that it will carefully consider the value of mobile technology in clinical research. By and large, the process of testing and approving new drugs and therapies has remained unchanged for the past 50 years. Today, data collected in everyday devices like smartphones and wearable fitness trackers could make clinical trials safer for patients and provide meaningful data to the FDA, write Barbara Elashoff and Glen de Vries of Medidata Solutions.